T-POC Quantitative Testing Platform – Product Brochure
SurfaceSurvey™ – OSD Patient Questionnaire
Peer-Reviewed Article entitled “How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives“; Chester T. et al. Clinical Ophthalmology 2023 Jun 5;17:1587-1604.
Interpretation and Application of T-POC Quantitative Testing Results
T-POC Lateral Flow Reader Overview & Troubleshooting Guide
Lateral Flow Reader – Instructions for Use
Biovance 3L Ocular – Overview Sheet
Biovance 3L Ocular – Clinical Application Process
Biovance 3L Ocular – Clinical Application Process [VIDEO]
Biovance 3L Ocular – Pterygium Surgery Application Process
Biovance 3L Ocular – Glueless, Sutureless Pterygium Surgery [VIDEO]
Biovance 3L Ocular – Order Form
Biovance 3L Ocular – Insurance Verification Form
2024 Medicare Ocular Reimbursement Codes Flashcard
Biovance 3L Ocular – Benchtop Study Reprint
Biovance 3L Ocular – Case Study – Anterior Membrane Dystrophy
Peer-Reviewed Article entitled “An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study”; Mao Y. et al; J Biomed Mater Res. 2022;1–17.
Peer-Reviewed Article entitled “Surgical Time and Postoperative Symptoms Study in Pterygium Excision and Amniotic Membrane Graft Using Celularity Triple Layer Dehydrated Amniotic Membrane“; Rivera-Morales P. et al; Clin Ophthal 2023:17;1967-1974. https://doi.org/10.2147/OPTH.S410452
Ophthalmology Times Article – Novel Amniotic Membrane: A Step Ahead of Other Scaffolds for Pterygia
Ophthalmology Times Article – 3-layer amniotic membrane successfully treats severe case of keratoconjunctivitis sicca
Healio Article – Biovance 3L Ocular effective in patients with chronic ocular surface disease
eyetube Video: Glueless, Sutureless Pterygium Surgery With Amniotic Membrane
Verséa is a registered trademark of Verséa Health, Inc.
©2024 Verséa Ophthalmics, Inc. All rights reserved.